Chamber and committees

Public Health Scotland (PHS) reports that the 2024-25 flu season in Scotland had the highest number of flu cases reported in recent years. Flu case numbers reached their highest levels between week 50 of 2024 and week 1 of 2025, and remained high in weeks 2 and 3 of 2025 as well. England, Wales and Northern Ireland also reported peak levels of infection around December 2024. While flu cases often rise over the festive period, this sustained high level of infection in the community was unusual compared to previous seasons.

As expected with the high levels of flu circulating during the early part of the winter season, proportionate numbers of flu-related hospital admissions followed in late December and early January, with deaths rising briefly thereafter. Epidemiological information on respiratory infection activity across Scotland can be found here.

PHS are currently undertaking a series of analyses of the flu season, including mortality rates.

Whilst high numbers of flu cases were reported over the winter season, there was no evidence to suggest that this season's flu caused more severe illness than in previous years or led to unexpectedly high rates of hospitalisation or a proportionally greater number of deaths.

A recent Eurosurveillance paper analysing the 2024-25 season, along with interim vaccine effectiveness (VE) data from the UK and Europe and including Scotland’s hospital data, showed that flu vaccines provided similar levels of protection against severe influenza disease in hospital settings as in previous years. VE against influenza A in hospitals ranged from 33% to 56%, and VE against influenza B was higher at 58%.

PHS continues to analyse data from the current and historical seasons to understand whether particular groups are more at risk for severe outcomes, with the goal of ensuring that appropriate public health action is taken as warranted.

In order to protect people and the NHS this coming winter it will be critical to maximise uptake across all eligible groups. The Scottish Government urges all those who are eligible to come forward in winter 2025 to receive their flu vaccine. We will continue to work with PHS and other partners within the Scottish Vaccination and Immunisation Programme to look at ways to improve uptake across the board.

The Scottish Government recognises that pulmonary rehabilitation is an important element of respiratory care and acknowledges the significant impact this treatment can have on people living with respiratory conditions.

In 2024 we worked with stakeholders, including many respiratory physiotherapists and nurse specialists, to develop a service specification for effective pulmonary rehabilitation services across Scotland. These recommendations have been shared with NHS Boards.

We will continue to work with NHS Boards and key partners, including the Centre for Sustainable Delivery, to ensure these recommendations are implemented.

I refer the member to the answer to question S6W-37115 on 6 May 2025. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

The UK Government undertakes scoping assessments prior to negotiations, and impact assessments on completion of an FTA, which detail the likely economic, social and environmental impacts of a new FTA. Those consider opportunities for increased trade in environmental goods and impacts on trade with third countries.

In our engagement with the UK Government on all trade negotiations, the Scottish Government has consistently requested more detailed assessments of the economic impacts on Scotland. We believe that before embarking on the negotiation of such agreements, the UK Government should be fully aware of their likely impacts across all parts of the UK. Net zero and environmental commitments should be a core part of scoping and impact assessments.

I refer the member to the answer to question S6W-36866 on 6 May 2025. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Teacher Workforce Planning Advisory Group figures are indicative and are provided by universities at the start of the academic session. Official Statistics from the Higher Education Statistics Agency, covering 2024-25, will be available in early 2026. These will provide the most accurate figures on enrolments into Initial Teacher Education (ITE) programmes.

We are taking action to encourage more people into teaching, including in the hardest to fill teaching subjects.

Local authorities are responsible for the recruitment and deployment of teaching staff and we are providing them with £186.5 million this year as part of an agreement to restore teacher numbers to 2023 levels. We will continue to support local authorities to maximise the number of teaching of jobs available, including through the joint Education and Childcare Assurance Board.

Our Teaching Bursary Scheme provides a £20,000 bursary to career changers wishing to undertake a one year Postgraduate Diploma in Education (PGDE) in the hardest to fill teaching subjects, including STEM subjects and modern languages.

We have asked Strategic Board for Teacher Education to develop advice on how to encourage more people into teaching, particularly in subjects that are challenging to fill.

Targets for secondary ITE PGDE courses have also been maintained at 2,000 for the 2025-26 academic year and are published on the Scottish Funding Council website - Intake Targets for Initial Teacher Education in AY 2025-26 - Scottish Funding Council

Since 2018 732 bursaries have been awarded to individuals who may not otherwise have applied for teacher training in STEM and modern language subjects.

The bursary scheme has been effective in increasing the number of teachers teaching in these hard-to-fill subjects.

Bursaries for independent schools are a matter for the proprietors of each institution, as each independent school is a private company. It is for the school itself to administer and provide bursaries for pupils to attend their establishment.

We continue to engage with the UK Government on this matter. My officials have been assured by the UK Government that their mailbox for school enquiries remains open. We have provided this to all Scottish independent schools, should they wish to contact them.

The provision of healthcare services, including medicines, is the responsibility of local NHS Health Boards, and it is for individual Health Boards to consider the implementation of any new treatment within their services in order to meet their local population needs.

The Centre for Sustainable Delivery are having initial conversations about the potential to undertake Parkinson’s Disease pathway work, which we understand would help to explore and articulate pathways for therapies for advanced and complex Parkinson’s Disease.

The Scottish Government has committed to investing rebates from the Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (VPAG) to fund the New Medicines Fund (NMF), which provides additional top-up funding to territorial Health Boards to support the cost of introducing new medicines.

The provision of healthcare services, including medicines, is the responsibility of local NHS Health Boards, and it is for individual Health Boards to consider the implementation of any new treatment within their services in order to meet their local population needs.

The Centre for Sustainable Delivery are having initial conversations about the potential to undertake Parkinson’s Disease pathway work, which we understand would help to explore and articulate pathways for therapies for advanced and complex Parkinson’s Disease.

Health Boards have 90 days from first receiving Scottish Medicines Consortium (SMC) advice in which to determine whether to make an SMC-recommended medicine (or an equivalent) available locally. This provides Health Boards with time to consider any issues associated the implementation of the medicine, such as changes to the care pathway and staff training.

We are also committed to supporting the national implementation of SMC advice and we have several ongoing programmes to address some of these implementation challenges further upstream of SMC decision making.